我院34例注射用甲氨蝶呤不良反应报告的回顾性分析

摘要/Abstract

摘要： 目的了解注射用甲氨蝶呤不良反应的临床特点,以期为临床安全合理用药提供参考。方法收集2005~2012年我院34例注射用甲氨蝶呤不良反应报告,采用回顾性研究的方法,对其年龄、性别、用药情况、不良反应的类型以及主要临床表现等进行统计与分析。结果34例患者中男24例（70.59%）,女10例（29.41%）。年龄8~33岁,其中11~15岁共15例（44.12%）。注射用甲氨蝶呤所致不良反应从用药后10分钟到7日后皆可发生。不良反应累及多个系统-器官,临床表现复杂多样。其中以皮肤及其附件损害最多,其次是消化系统损害、全身性损害、神经系统损害、黏膜损害和生殖系统损害等。结论注射用甲氨蝶呤在大剂量使用时应引起临床高度重视,加强不良反应监测,早期发现给予对症治疗,保障患者用药安全。

关键词: 甲氨蝶呤, 药品不良反应, 回顾性分析

Abstract: ObjectiveTo investigate the clinical features of the adverse reactions caused by methotrexate, provide reference for rational use of methotrexate. Methods 34 cases of methotrexate adverse reaction reports in Beijing Jishuitan hospital were retrospectively analyzed on the age, sex, administration and dosage, the type of adverse reactions, the main clinical manifestations from 2005 to 2012. Results24 patients (70.59%) were male in 34 cases and 10 were female (29.41%). Age range was 8 to 33 years old, 15 cases were 11 to 15 years old (44.12%). The adverse reactions induced by methotrexate could occur in ten minutes after administration, could also occur in seven days. Adverse reactions involved multiple systems, and the clinical manifestations were complicated and diversified. Damage to the skin and its appendages was the hightest, followed by the digestive system, systemic damage, nervous system, mucosal damage and reproductive system. ConclusionThe analysis concludes that adverse events of high-dosage methotrexate deserve more clinical attention, strengthening the monitoring of adverse reactions, early detecting of symptomatic treatment and protecting patients medication safely.

Key words: methotrexate, adverse drug reactions, retrospective analysis

中图分类号:

R979.1

杨雨薇, 董迪, 宋菲. 我院34例注射用甲氨蝶呤不良反应报告的回顾性分析[J]. 中国药物警戒, 2014, 11(9): 557-560.

YANG Yu-wei, DONG Di, SONG Fei. Retrospective Analysis of 34 Cases of Adverse Reactions Induced by Methotrexate[J]. Chinese Journal of Pharmacovigilance, 2014, 11(9): 557-560.

参考文献

[1] Jaffe N, Gorlick R. High-Dose Methotrexate in Osteosarcoma:Let the Questions Surcease-Time for Final Acceptance[J]. J Clin Oncol,2008,26(27):4365-4366.
[2] Tett S E, Triggs E J. Use of methotrexate in older patients. A risk-benefit assessment[J]. Drugs Aging 1996,9(6):458-471.
[3] Alkins S A, Byrd J C, Morgan S K, et al. Anaphylactoid reactions to methotrexate[J]. Cancer,1996,77(10):2123-2126.
[4] Lamki Z al, Thomas E, Banna N el, et al. Acute urticaria and hepatitis complicating high-dose methotrexate therapy[J]. Med Pediatr Oncol,1995,24(2):137-140.
[5] Searles G, McKendry R J. Methotrexate pneumonitis in rheumatoid arthritis: potential risk factors. Four case reports and a review of the literature[J]. J Rheumatol,1987,14(6):1164-1171.
[6] Meadows A T, Evans A E. Effects of chemotherapy on the central nervous system. A study of parenteral methotrexate in long-term survivors of leukemia and lymphoma in childhood[J]. Cancer,1976,37(2 Suppl):1079-1085.
[7] Perez C, Suto W W, Wang Y M, et al. Evaluation of overall toxicity of high-dose methotrexate regimens[J]. Med Pediatr Oncol, 1979,6(3):219-228.
[8] 危晴岚,王友芳.大剂量甲氨蝶呤不良反应分析及防治[J].海峡药学,2007,19（11）：117.
[9] 任晓蕾,于冉,李玉珍.1996~2009年我院74例甲氨蝶呤致不良反应报告分析[J].中国医院用药评价与分析,2010,10（5）:467-469.
[10] 张林,徐建立,陈国强,等.大剂量甲氨蝶呤在骨肉瘤化疗中的应用及并发症的处理[J].中国骨肿瘤骨病,2010,9(6):481-483.
[11] 孙黎明,徐万鹏,张林,等.儿童骨肉瘤综合治疗的效果[J].实用儿科临床杂志,2011,26(15):1178-1180.
[12] 周爱春,刘云霞,杨洁文,等.骨肉瘤患者大剂量甲氨蝶呤化疗导致口腔溃疡的观察及护理[J].浙江医学 ,2013,35(23):2134-2135.
[13] 姚晋囡,曹晶.护理干预对骨肉瘤大剂量甲氨蝶呤化疗患者血药浓度监测的重要性[J].中华现代护理杂志,2010,16(20):2417-2418.
[14] 马胜鑫,何绥平.甲氨蝶呤-甲酰四氢叶酸钙治疗骨肉瘤的不良反应及处置[J].药物不良反应杂志,2001,3(2):107-109.
[15] 束华,刘伟.大剂量甲氨蝶呤化疗不良反应的观察与护理[J].实用肿瘤学杂志,2011,25(2):162-164.
[16] 孟岩,梁筱灵,宪莹,等.大剂量甲氨蝶呤治疗儿童急性淋巴细胞白血病的安全性与疗效分析[J].儿科药学杂志,2010,16(5):7-11.
[17] 湛洁谊,叶铁真,吴梓梁,等.大剂量甲氨蝶呤治疗急性淋巴细胞白血病[J].实用儿科临床杂志,2005,20(7):652-654.
[18] 刘瑛,万伍卿,邓兵,等.大剂量甲氨蝶呤治疗急性淋巴细胞白血病的不良反应[J].实用儿科临床杂志,2006,21(3):170-171.
[19] 王平,李艳玲,曹志新.大剂量甲氨蝶呤治疗急性淋巴细胞白血病的不良反应及护理对策[J].中国肿瘤临床与康复,2013,20（5）：527-529.
[20] 魏筱华,郑雪莲,邹德琴,等. 大剂量甲氨蝶呤治疗小儿急性淋巴细胞白血病的血药浓度与不良反应相关性探讨[J].中国现代应用药学,2011,28（1）：79-81.
[21] 何晓静,邱枫,肇丽梅,等.东北地区小儿急淋白血病大剂量甲氨蝶呤化疗后血药浓度与不良反应相关性分析[J].中国现代医学杂志,2010,20(5):718-722.
[22] 唐薇,王雅香,张东林,等.甲氨蝶呤治疗小儿急性白血病时血液和脑脊液中浓度监测及不良反应[J].中国临床药学杂志,2002,11(3):150-152.